BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28052283)

  • 1. The Feasibility of Conservative Management for Morbidly Adherent Placenta Accidentally Encountered after Vaginal Delivery.
    Cui R; Lu J; Zhang Z; Bai H
    Gynecol Obstet Invest; 2017; 82(5):494-499. PubMed ID: 28052283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases].
    Daney de Marcillac F; Lecointre L; Guillaume A; Sananes N; Fritz G; Viville B; Boudier E; Nisand I; Gaudineau A; Langer B; Akladios CY
    J Gynecol Obstet Biol Reprod (Paris); 2016 Oct; 45(8):849-858. PubMed ID: 27118678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative management of morbidly adherent placenta: expert review.
    Fox KA; Shamshirsaz AA; Carusi D; Secord AA; Lee P; Turan OM; Huls C; Abuhamad A; Simhan H; Barton J; Wright J; Silver R; Belfort MA
    Am J Obstet Gynecol; 2015 Dec; 213(6):755-60. PubMed ID: 25935779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Standardized Approach for Transfusion Medicine Support in Patients With Morbidly Adherent Placenta.
    Panigrahi AK; Yeaton-Massey A; Bakhtary S; Andrews J; Lyell DJ; Butwick AJ; Goodnough LT
    Anesth Analg; 2017 Aug; 125(2):603-608. PubMed ID: 28640786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hemorrhage in abnormally invasive placenta according to its management.
    Pinto PV; Machado AP; Montenegro N
    J Matern Fetal Neonatal Med; 2017 Sep; 30(18):2139-2145. PubMed ID: 27678283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management of morbidly adherant placenta - a case report and review of literature.
    Khan M; Sachdeva P; Arora R; Bhasin S
    Placenta; 2013 Oct; 34(10):963-6. PubMed ID: 23937959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage].
    Chen YT; Xu LF; Sun HL; Li HQ; Hu RM; Tan QY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):273-7. PubMed ID: 20646539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conservative treatment of placenta accreta].
    Courbière B; Bretelle F; Porcu G; Gamerre M; Blanc B
    J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):549-54. PubMed ID: 14593301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal outcome after conservative management of abnormally invasive placenta.
    Su HW; Yi YC; Tseng JJ; Chen WC; Chen YF; Kung HF; Chou MM
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):353-357. PubMed ID: 28600047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planned conservative management of placenta accreta - experience of a regional general hospital.
    Lo TK; Yung WK; Lau WL; Law B; Lau S; Leung WC
    J Matern Fetal Neonatal Med; 2014 Feb; 27(3):291-6. PubMed ID: 23796273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine Artery Embolization for Management of Primary Postpartum Hemorrhage Associated with Placenta Accreta.
    Wang Z; Li X; Pan J; Zhang X; Shi H; Yang N; Jin Z
    Chin Med Sci J; 2016 Nov; 31(4):228-232. PubMed ID: 28065219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 47 cases of placenta accreta in the second and third trimesters].
    Zhang C; Liu XY; Fan GS; Yang JQ; Liu JT; Bian XM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):506-9. PubMed ID: 19080513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morbidly adherent placenta: diagnosis and management options.
    Hayes E; Ayida G; Crocker A
    Curr Opin Obstet Gynecol; 2011 Dec; 23(6):448-53. PubMed ID: 22002113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of placenta accreta in the second trimester of pregnancy].
    Yu M; Liu XY; Dai Q; Cui QC; Jin ZY; Lang JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):501-4. PubMed ID: 21050552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of placenta accreta: to leave or remove the placenta?
    Perez-Delboy A; Wright JD
    BJOG; 2014 Jan; 121(2):163-9; discussion 169-70. PubMed ID: 24373590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative approach to the management of morbidly adherent placentae.
    Meyer NP; Ward GH; Chandraharan E
    Ceylon Med J; 2012 Mar; 57(1):36-9. PubMed ID: 22453709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta.
    Pan Y; Zhou X; Yang Z; Cui S; De W; Sun L
    Int J Gynaecol Obstet; 2017 Apr; 137(1):45-50. PubMed ID: 28098341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative management of post-partum hemorrhage secondary to placenta previa-accreta with hypogastric artery ligation and endo-uterine hemostatic suture.
    Rauf M; Ebru C; Sevil E; Selim B
    J Obstet Gynaecol Res; 2017 Feb; 43(2):265-271. PubMed ID: 27987348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine artery embolization for the management of secondary postpartum haemorrhage associated with placenta accreta.
    Li X; Wang Z; Chen J; Shi H; Zhang X; Pan J; Liu W; Yang N; Jin Z; Lang J
    Clin Radiol; 2012 Dec; 67(12):e71-6. PubMed ID: 22974568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonremoval of an abnormally invasive placenta at cesarean section with postoperative uterine artery embolization.
    Chung MY; Cheng YK; Yu SC; Sahota DS; Leung TY
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1250-5. PubMed ID: 23937444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.